In the afternoon, the committee met in open session to hear an overview of the research programs in the Laboratory of Biochemistry and Vascular Biology in the Division of Blood Components and Devices, Office of Blood Research and Review, Center for Biologics Evaluation and Research, FDA.
On March 21, 2019, the committee met in open session to discuss blood donation policies regarding men who have sex with men (MSM). The committee heard presentations on the current epidemiology of HIV in the United States; global developments in MSM blood donor deferral policies; and data on HIV incidence and prevalence among blood donors from the Transfusion-Transmitted Infection Monitoring System. The committee discussed a proposed HIV risk questionnaire study. In addition, the committee discussed a proposal for the use of pathogen reduction technology as an alternative procedure to a time-based deferral for MSM.